Pennant Group Inc (PNTG) - Net Assets

Latest as of March 2026: $389.44 Million USD

Based on the latest financial reports, Pennant Group Inc (PNTG) has net assets worth $389.44 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($956.48 Million) and total liabilities ($567.05 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore Pennant Group Inc (PNTG) cash flow conversion to assess how effectively this company generates cash.

Key Net Assets Metrics

Metric Value
Current Net Assets $389.44 Million
% of Total Assets 40.72%
Annual Growth Rate 25.73%
5-Year Change 227.59%
10-Year Change N/A
Growth Volatility 33.81

Pennant Group Inc - Net Assets Trend (2017–2025)

This chart illustrates how Pennant Group Inc's net assets have evolved over time, based on quarterly financial data. Also explore PNTG total asset value for the complete picture of this company's asset base.

Annual Net Assets for Pennant Group Inc (2017–2025)

The table below shows the annual net assets of Pennant Group Inc from 2017 to 2025. For live valuation and market cap data, see market value of Pennant Group Inc.

Year Net Assets Change
2025-12-31 $374.25 Million +19.97%
2024-12-31 $311.96 Million +114.39%
2023-12-31 $145.51 Million +15.80%
2022-12-31 $125.66 Million +9.99%
2021-12-31 $114.24 Million +12.92%
2020-12-31 $101.17 Million +42.27%
2019-12-31 $71.11 Million +8.92%
2018-12-31 $65.29 Million +8.97%
2017-12-31 $59.92 Million --

Equity Component Analysis

This analysis shows how different components contribute to Pennant Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 8680000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings $86.80 Million 26.10%
Common Stock $35.00K 0.01%
Other Components $245.77 Million 73.89%
Total Equity $332.60 Million 100.00%

Pennant Group Inc Competitors by Market Cap

The table below lists competitors of Pennant Group Inc ranked by their market capitalization.

Company Market Cap
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
$1.18 Billion
Amoy Diagnostics Co Ltd
SHE:300685
$1.18 Billion
Dazhong Transportation Group Co Ltd A
SHG:600611
$1.18 Billion
Jiangxi GETO New Materials Corporation Limited
SHE:300986
$1.18 Billion
Zhejiang Chunhui Intelligent Control Co. Ltd.
SHE:300943
$1.18 Billion
Fox-Wizel Ltd
TA:FOX
$1.18 Billion
Beijing eGOVA
SHE:300075
$1.18 Billion
Shenzhen Tatfook Tech
SHE:300134
$1.18 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Pennant Group Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 293,283,000 to 332,603,000, a change of 39,320,000 (13.4%).
  • Net income of 29,578,000 contributed positively to equity growth.
  • New share issuances of 552,000 increased equity.
  • Other factors increased equity by 9,190,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $29.58 Million +8.89%
Share Issuances $552.00K +0.17%
Other Changes $9.19 Million +2.76%
Total Change $- 13.41%

Book Value vs Market Value Analysis

This analysis compares Pennant Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.61x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 17.31x to 3.61x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 $1.96 $34.00 x
2018-12-31 $1.99 $34.00 x
2019-12-31 $2.40 $34.00 x
2020-12-31 $3.20 $34.00 x
2021-12-31 $3.60 $34.00 x
2022-12-31 $4.01 $34.00 x
2023-12-31 $4.65 $34.00 x
2024-12-31 $9.17 $34.00 x
2025-12-31 $9.42 $34.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Pennant Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 8.89%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 3.12%
  • • Asset Turnover: 0.98x
  • • Equity Multiplier: 2.91x
  • Recent ROE (8.89%) is below the historical average (11.11%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2017 17.94% 3.93% 2.84x 1.61x $4.37 Million
2018 28.08% 5.48% 2.91x 1.76x $10.10 Million
2019 3.58% 0.75% 0.76x 6.30x $-4.57 Million
2020 16.30% 4.03% 0.77x 5.25x $6.09 Million
2021 2.45% 0.61% 0.83x 4.81x $-8.32 Million
2022 5.49% 1.40% 0.92x 4.23x $-5.46 Million
2023 9.53% 2.46% 1.01x 3.85x $-654.90K
2024 7.69% 3.24% 1.02x 2.32x $-6.77 Million
2025 8.89% 3.12% 0.98x 2.91x $-3.68 Million

Industry Comparison

This section compares Pennant Group Inc's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

  • Industry: Medical Care Facilities
  • Average net assets among peers: $361,876,117
  • Average return on equity (ROE) among peers: 9067.21%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Pennant Group Inc (PNTG) $389.44 Million 17.94% 1.46x $1.18 Billion
Acadia Healthcare Company Inc (ACHC) $96.36 Million -36.21% 3.29x $1.52 Billion
Addus HomeCare Corporation (ADUS) $970.49 Million 7.58% 0.46x $1.74 Billion
agilon health Inc (AGL) $661.02 Million -39.73% 1.63x $264.44 Million
Airsculpt Technologies Inc (AIRS) $120.39 Million -1.84% 0.42x $272.31 Million
Amedisys Inc (AMED) $454.23 Million -18.40% 0.61x $3.32 Billion
AMN Healthcare Services Inc (AMN) $170.84 Million -71.51% 1.28x $624.22 Million
American Shared Hospital Service (AMS) $24.05 Million -1.30% 1.98x $8.87 Million
American Oncology Network Inc. (AONC) $24.17K 90834.23% 1.03x $292.48 Million
Ardent Health Partners, Inc. (ARDT) $760.28 Million -4.69% 2.12x $1.35 Billion
Astrana Health Inc (ASTH) $361.06 Million 3.91% 1.02x $2.15 Billion

About Pennant Group Inc

NASDAQ:PNTG USA Medical Care Facilities
Market Cap
$1.18 Billion
Market Cap Rank
#8407 Global
#2340 in USA
Share Price
$34.00
Change (1 day)
+0.24%
52-Week Range
$22.07 - $36.90
All Time High
$66.48
About

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, educ… Read more